908 Devices
MASS | NASDAQ
$9.19
-$0.55 (-5.65%)
At close: Nov 16, 2026, 4:00 PM ET
$9.19
$0.00 (0.00%)
After-hours:
Nov 16, 2026, 4:10 PM ET
908 Devices Company Profile
Company profile explainedCompany Profile
908 Devices Inc. provides purpose-built handheld mass spectrometry and fourier transform infrared (FTIR) devices for use in vital health and safety applications. The company’s products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; XplorIR, a handheld device that uses FTIR spectroscopy to identify, quantify, and track gases and vapors; ThreatID, a portable FTIR device that rapidly detects and identifies approximately 28,000 unknown gas, vapor, powder, and liquid chemical hazards; ProtectIR, a handheld FTIR device that can identify approximately 23,000 solid and liquid chemical hazards; and VipIR, a handheld 3-in-1 analyzer that integrates FTIR, Raman spectroscopy, and smart spectral processing (SSP), a proprietary algorithm, to provide a single result from just one sample. It operates in the United States, Europe, the Middle East, Africa, the Asia Pacific, and rest of Americas. The company was incorporated in 2012 and is headquartered in Burlington, Massachusetts.
Key Executives
| Name | Position |
|---|---|
| Kevin J. Knopp | Co-Founder, Chief Executive Officer, President & Director |
| Joseph H. Griffith | Chief Financial Officer & Treasurer |
| Christopher David Brown | Co-Founder, Board Advisor & Director |
| John Kenneweg | Senior Vice President of Sales and Product Marketing |
| Julie Cincotti | Global Head of Human Resources |
| Kevin McCallion | Senior Vice President of Products and Production |
| Kola Otitoju | Chief Business & Strategy Officer |
| Mark S. Levine | Chief Legal, Administrative Officer & Corporate Secretary |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Oct 27, 2026 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Oct 09, 2026 | 4 | Filing |
| Oct 08, 2026 | 4 | Filing |
| Oct 01, 2026 | 4 | Filing |
| Sep 25, 2026 | 4 | Filing |
| Sep 17, 2026 | 4 | Filing |
| Sep 04, 2026 | 4 | Filing |
| Aug 27, 2026 | 4 | Filing |
| Aug 24, 2026 | 4 | Filing |
| Aug 17, 2026 | 4 | Filing |
908 Devices
| Country | United States |
| IPO Date | Dec 18, 2020 |
| Industry | Medical - Specialties |
| Sector | Healthcare |
| Employees | 172 |
| CEO | Kevin J. Knopp |
Contact Details
44 3rd Avenue Burlington,
Massachusetts 01803 United States
Stock Details
| Ticker Symbol | MASS |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001555279 |
| CUSIP Number | 65443P102 |
| ISIN Number | US65443P1021 |
| SIC Code | 3829 |
Add to Watchlist
Select watchlists to add or remove MASS